Cell lines used in prostate cancer research: a compendium of old and new lines--part 2.
about
Cancer Cell Line Panels Empower Genomics-Based Discovery of Precision Cancer MedicineThe current state of preclinical prostate cancer animal models.Spheroid culture of LuCaP 147 as an authentic preclinical model of prostate cancer subtype with SPOP mutation and hypermutator phenotype.Establishment and genomic characterization of mouse xenografts of human primary prostate tumors.Identification of a LNCaP-specific binding peptide using phage display.Tissue slice grafts: an in vivo model of human prostate androgen signalingTargeting the regulation of androgen receptor signaling by the heat shock protein 90 cochaperone FKBP52 in prostate cancer cells.Molecular genetics of prostate cancer: new prospects for old challengesAndrogen metabolism in prostate cancer: from molecular mechanisms to clinical consequencesLongitudinal MRI contrast enhanced monitoring of early tumour development with manganese chloride (MnCl2) and superparamagnetic iron oxide nanoparticles (SPIOs) in a CT1258 based in vivo model of prostate cancer.Induced pluripotency of human prostatic epithelial cells.CoMAGC: a corpus with multi-faceted annotations of gene-cancer relations.Prostate cancer targeting motifs: expression of αν β3, neurotensin receptor 1, prostate specific membrane antigen, and prostate stem cell antigen in human prostate cancer cell lines and xenografts.In vitro and in vivo model systems used in prostate cancer research.Enhanced G2/M Arrest, Caspase Related Apoptosis and Reduced E-Cadherin Dependent Intercellular Adhesion by Trabectedin in Prostate Cancer Stem CellsThe use of chelated radionuclide (samarium-153-ethylenediaminetetramethylenephosphonate) to modulate phenotype of tumor cells and enhance T cell-mediated killingAutophagy regulates lipolysis and cell survival through lipid droplet degradation in androgen-sensitive prostate cancer cellsAuger Radiopharmaceutical Therapy Targeting Prostate-Specific Membrane AntigenInvestigation of the In Vitro and In Vivo efficiency of RM-532-105, a 17β-hydroxysteroid dehydrogenase type 3 inhibitor, in LAPC-4 prostate cancer cell and tumor modelsMKK4 suppresses metastatic colonization by multiple highly metastatic prostate cancer cell lines through a transient impairment in cell cycle progression.Dissociation of epithelial and neuroendocrine carcinoma lineages in the transgenic adenocarcinoma of mouse prostate model of prostate cancer.Stage matters: choosing relevant model systems to address hypotheses in diet and cancer chemoprevention research.Convergence of oncogenic and hormone receptor pathways promotes metastatic phenotypes.Prostate cell cultures as in vitro models for the study of normal stem cells and cancer stem cells.Gene signatures distinguish stage-specific prostate cancer stem cells isolated from transgenic adenocarcinoma of the mouse prostate lesions and predict the malignancy of human tumors.From bench to cageside: Risk assessment for rodent pathogen contamination of cells and biologics.Comprehensive functional annotation of 77 prostate cancer risk loci.Cooperative behavior of the nuclear receptor superfamily and its deregulation in prostate cancer.The direct inhibitory effect of dutasteride or finasteride on androgen receptor activity is cell line specific.Characterization of the androgen receptor in a benign prostate tissue-derived human prostate epithelial cell line: RC-165N/human telomerase reverse transcriptase.Suppression of Prostate Cancer Metastasis by DPYSL3-Targeted saRNA.Generation of a C57BL/6 MYC-Driven Mouse Model and Cell Line of Prostate Cancer.Fibroblasts prolong serum prostate-specific antigen decline after androgen deprivation therapy in prostate cancer.Probing the prostate tumour microenvironment I: impact of glucose deprivation on a cell model of prostate cancer progression.Prostate cell lines as models for biomarker discovery: performance of current markers and the search for new biomarkers.Cytometric comparisons between circulating tumor cells from prostate cancer patients and the prostate-tumor-derived LNCaP cell line.Tissue culture media supplemented with 10% fetal calf serum contains a castrate level of testosterone.F-actin reorganization by V-ATPase inhibition in prostate cancer.Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling.V-ATPase-dependent repression of androgen receptor in prostate cancer cells.
P2860
Q26800337-2AF508BC-195C-421E-B56D-C305EEA0B11AQ30418797-6C45E5CC-AD45-4B2A-868E-CEDAA7ECF887Q30585006-064C30B0-5197-4B78-9BBE-42D0D6E6B1AEQ33745240-86B543A4-0731-485F-903B-5870EA6E49C8Q33911470-13F816DA-27C5-4ECD-9606-A59869521885Q33947237-0CA55540-D7C5-4EC6-AB34-6B3216F300BAQ33951397-53A4A5E7-EF11-43AF-9856-97EF7BD2634AQ34127462-BF7BFECB-0D2B-4424-97DC-85D6BC9C52EFQ34283623-0B2A1083-F056-4986-8823-3398011EBC87Q34333320-751992D6-BD40-4ABA-8902-59EB9555C820Q34745924-0BFA224C-4743-40B7-BFE9-D8EDA720C697Q35041814-3FC23469-4485-42BE-A606-180686E4B729Q35195521-74BCA829-B459-44C6-ADDA-25E8FEE40299Q35806390-00DEFED3-8988-46F1-A6A9-5CDB52263BB7Q35814987-0A456AC6-D81D-4825-A174-A309C15F5922Q36126003-155827E0-2895-4FC3-AA43-2A51927154FEQ36162068-ACBB10BE-9B70-4710-BC89-0AB6378BD253Q36252485-442D1C86-37CD-4A6E-B40E-996276AE1CA9Q36275656-17157994-3BB1-4335-92F0-2D05F9466685Q36301750-C91CE767-FAE5-4598-ACCC-897C5B9FE1CFQ36357373-266DFDF7-C348-4A64-8B6E-9F19DC171120Q36394882-A203C056-F74B-4ABA-9F12-43443A5AA7E6Q36497254-C1FA310C-B95B-4DA1-A07D-2D66D5ED80FFQ36994174-57753E2A-425C-4D03-95E9-1FC5B3DBC95BQ37124560-BEB0FC32-3551-4768-802A-F60C9FFC14F3Q37174351-CDE89C41-72D1-49AD-AA6A-DD4248D4C6AFQ37533894-9B3DC4F9-C982-434E-BD7C-E6D722226ED3Q37537548-02C664C5-0457-4907-ACD3-E58530FE1BA4Q37711593-F57CB6CD-36EC-43FF-9CDE-A643FAABD6BDQ38308020-8B493FFF-89CC-4C90-95D4-B42142CD1048Q38714528-ADCA8F44-D29C-475A-A3D1-BCB515A239CAQ38768422-B37CA421-B977-4553-8958-07CFE3804D17Q38814063-3F09E9C3-6A62-4836-BC8E-A28761437F6CQ39021762-908DFBEE-9BC7-45C3-8FD8-0692C9845535Q39033586-81C6FCF2-F0C4-4F68-B362-09C6A95FEDDEQ39401363-AE072C3D-BA1E-42E9-9ECC-4D142F3637B9Q39813195-E4DE0B5B-F49F-43C7-9EB6-5CA684C9ED18Q47149285-7742BA4E-F2C1-43E9-94CD-B061922F7AAAQ47670505-4DF4C751-8739-4FF4-B754-1DA1F08E42A8Q55508834-CB3B8B87-D628-4035-BD00-AF7EA8574098
P2860
Cell lines used in prostate cancer research: a compendium of old and new lines--part 2.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Cell lines used in prostate cancer research: a compendium of old and new lines--part 2.
@ast
Cell lines used in prostate cancer research: a compendium of old and new lines--part 2.
@en
type
label
Cell lines used in prostate cancer research: a compendium of old and new lines--part 2.
@ast
Cell lines used in prostate cancer research: a compendium of old and new lines--part 2.
@en
prefLabel
Cell lines used in prostate cancer research: a compendium of old and new lines--part 2.
@ast
Cell lines used in prostate cancer research: a compendium of old and new lines--part 2.
@en
P1476
Cell lines used in prostate cancer research: a compendium of old and new lines--part 2.
@en
P2093
P304
P356
10.1097/01.JU.0000149989.01263.DC
P407
P577
2005-02-01T00:00:00Z